$37.02
-0.75[-1.99%]
At close: Apr 24
$37.02
0[0.00%]
After Hours: 4:03PM EDT
Celldex Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Celldex Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | PM | CLDX | Q1 | -$0.62 | -$0.73 | — | — | $967.00K | $920.00K | — | — | Get Alert |
02/26/2024 | AM | CLDX | Q4 | -$0.56 | -$0.74 | -$0.83 | -12.16% | $1.61M | $840.00K | $4.13M | 391.90% | Get Alert |
11/02/2023 | PM | CLDX | Q3 | -$0.57 | -$0.68 | -$0.81 | -19.12% | $407.00K | $580.00K | $1.52M | 161.55% | Get Alert |
08/08/2023 | PM | CLDX | Q2 | -$0.77 | -$0.67 | -$0.65 | 2.99% | $163.00K | $530.00K | $268.00K | -49.43% | Get Alert |
05/04/2023 | PM | CLDX | Q1 | -$0.49 | -$0.63 | -$0.62 | 1.59% | $174.00K | $410.00K | $967.00K | 135.85% | Get Alert |
02/28/2023 | PM | CLDX | Q4 | -$0.43 | -$0.59 | -$0.56 | 5.08% | $333.00K | $260.00K | $1.61M | 520.38% | Get Alert |
11/09/2022 | PM | CLDX | Q3 | -$0.37 | -$0.58 | -$0.57 | 1.72% | $153.00K | — | $407.00K | — | Get Alert |
08/08/2022 | PM | CLDX | Q2 | -$0.34 | -$0.51 | -$0.77 | -50.98% | $3.48M | $400.00K | $163.00K | -59.25% | Get Alert |
05/05/2022 | PM | CLDX | Q1 | -$0.42 | -$0.45 | -$0.49 | -8.89% | $685.00K | $560.00K | $174.00K | -68.93% | Get Alert |
02/28/2022 | PM | CLDX | Q4 | -$0.55 | -$0.42 | -$0.43 | -2.38% | $3.79M | — | $333.00K | — | Get Alert |
11/09/2021 | PM | CLDX | Q3 | -$0.36 | -$0.37 | -$0.37 | 0.00% | $668.00K | $1.12M | $153.00K | -86.34% | Get Alert |
08/05/2021 | PM | CLDX | Q2 | -$0.50 | — | -$0.34 | — | $236.00K | $685.00K | $3.48M | 408.03% | Get Alert |
05/06/2021 | PM | CLDX | Q1 | -$0.73 | -$0.38 | -$0.42 | -10.53% | $2.73M | $685.00K | $685.00K | 0.00% | Get Alert |
03/29/2021 | PM | CLDX | Q4 | -$0.64 | — | -$0.55 | — | $887.00K | — | $3.79M | — | Get Alert |
11/05/2020 | PM | CLDX | Q3 | -$0.75 | — | -$0.36 | — | $546.00K | — | $668.00K | — | Get Alert |
08/06/2020 | PM | CLDX | Q2 | -$0.84 | -$0.58 | -$0.50 | 13.79% | $715.00K | $800.00K | $236.00K | -70.50% | Get Alert |
05/06/2020 | PM | CLDX | Q1 | -$1.40 | — | -$0.73 | — | $1.43M | — | $2.73M | — | Get Alert |
03/26/2020 | PM | CLDX | Q4 | -$0.81 | -$0.90 | -$0.64 | 28.89% | $1.76M | $810.00K | $887.00K | 9.51% | Get Alert |
11/12/2019 | PM | CLDX | Q3 | -$0.60 | -$0.84 | -$0.75 | 10.71% | $941.00K | $1.26M | $546.00K | -56.67% | Get Alert |
Celldex Therapeutics (CLDX) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 26, 2024 for Q4.
The Actual EPS was $-0.83, which missed the estimate of $-0.74.
The Actual Revenue was $4.1M, which beat the estimate of $840K.
Browse earnings estimates, EPS, and revenue on all stocks.